RS
BNGO icon

R Squared’s Bionano Genomics BNGO Stock Holding History

R Squared’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,771
Closed -$21.1K – 508
2025
Q4 		$21.1K Buy
+13,771
New +$23.8K 0.01% 492

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

R Squared's BNGO Position: Q1 2026 in Review

R Squared sold out of Bionano Genomics (BNGO) in Q1 2026, closing a stake of 13,771 shares — an estimated $21.1K sold.

R Squared first reported a position in BNGO in Q4 2025 and held it in 1 quarter. The position peaked at $21.1K in Q4 2025. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • R Squared reported no remaining Bionano Genomics position as of Q1 2026 after selling out during the quarter.
  • R Squared sold 13,771 Bionano Genomics shares in Q1 2026, an estimated $21.1K.
  • R Squared first reported a position in Bionano Genomics in Q4 2025 and held it in 1 quarter.
  • R Squared's Bionano Genomics position peaked at $21.1K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.